A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2004
12/29/2004	EP1257539B1 Amino pyrazole derivatives useful for the treatment of obesity and other disorders
12/29/2004	EP1216048B1 Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols
12/29/2004	EP1204646B1 1,4,5,6 -tetrahydropyrimidine derivative as a vitronectin inhibitor
12/29/2004	EP1196180B1 Treatment of angiogenesis dependent conditions with dextrin sulphate
12/29/2004	EP1189923B1 Aromatic and heterocyclic derivatives of phytosterols and/or phytostanols for use in treating or preventing cardiovascular disease
12/29/2004	EP1177178B1 Heterocyclically substituted benzimidazoles, the production and application thereof
12/29/2004	EP1135123B1 Use of isatin derivatives as ion channel activating agents
12/29/2004	EP1056729B1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia
12/29/2004	EP1045691B1 Statin-carboxyalkylether combinations
12/29/2004	EP1009400B1 Combination therapy comprising atorvastatin and an antihypertensive agent
12/29/2004	EP0967892B1 Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementaton and an energy supplement containing such an additive
12/29/2004	EP0920632B1 Methods for detection of autoimmune diseases
12/29/2004	EP0874626B1 Use of inhibitors of retinoic acid activity for wound healing
12/29/2004	EP0725635B1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/29/2004	CN1558950A Somatic cell derived embryonic stem cell and its differentiated cell
12/29/2004	CN1558946A New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
12/29/2004	CN1558907A Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
12/29/2004	CN1558905A Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
12/29/2004	CN1558897A Antidiabetic agents
12/29/2004	CN1558768A A pharmaceutical composition made from Chinese traditional medicine and preparation method thereof
12/29/2004	CN1558766A A method of reducing the 'in vivo' cholesterol ester transfer protein mediated transfer of cholesteryl esters between high density lipoproteins (HDL) and low density lipoproteins (LDL)
12/29/2004	CN1558764A Substituted urea neuropeptide Y Y5 receptor antagonists
12/29/2004	CN1558758A Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
12/29/2004	CN1558724A Herbal nutraceutical formulation for females/expectant mothers and its process of preparation
12/29/2004	CN1557954A Expression and application of transduction peptides - human insulinogen fusion protein
12/29/2004	CN1557842A Process for extracting polygonatum polysaccharides, preparing process for medical preparation and use thereof
12/29/2004	CN1557824A Silkworm excrement total alkaloid and its preparation method
12/29/2004	CN1557481A Natural nutrient for preventing and treating iron-deficiency anemia
12/29/2004	CN1557480A Preparation and application of insulin-like growth factors
12/29/2004	CN1557475A Beautifying and fat reducing nutrients composition
12/29/2004	CN1557471A Nutrient for preventing and treating type II diabetes and X-syndrome
12/29/2004	CN1557469A Natural calcium replenishing nutrient
12/29/2004	CN1557448A Gynostemma pentaphylla capsule
12/29/2004	CN1557444A Preparing process of sobering up and clearing away heat healthy product series
12/29/2004	CN1557407A Botanical medicine for preventing and treating arteriosclerosis and regulating blood fat and its processing method
12/29/2004	CN1557406A Producing method of red rice fat reducing tea
12/29/2004	CN1557405A Preparing process of antihyperglycemic tea with functions of inhibiting cholesterol synthesization
12/29/2004	CN1557402A Chinese herbal medicine preparation and its preparing process and application
12/29/2004	CN1557382A Glucoside compound preparation and its preparing process
12/29/2004	CN1557378A Medicine for treating diabetes
12/29/2004	CN1557371A Oral administered medicated wine for treating cardiovascular and cerebrovascular diseases
12/29/2004	CN1557370A Antihyperglycemic and oxidation resistant health products and preparing process thereof
12/29/2004	CN1557366A Medicine for treating children's microelement deficiency and its processing method
12/29/2004	CN1557352A Novel usage of chicory aqueous extract
12/29/2004	CN1557344A Processing technique for making active calcium by java tilapia bone
12/29/2004	CN1557319A Rosuvastatin dispersion tablet and its preparation method
12/29/2004	CN1557301A Compositions for senile diabetes patient blood sugar and blood fat reduction
12/29/2004	CN1557292A Formulation for improving human growth hormone release and its uses
12/29/2004	CN1557291A Nateglinide dispersant tablet and its preparation method
12/29/2004	CN1557287A The use of sulfonylureas and sulphonyl thiourea derivative in preparation of anti diabetes drug
12/29/2004	CN1557198A Method for reducing the glycemic index of food
12/29/2004	CN1182247C Sequence-specific DNA recombination in eukaryotic cells
12/29/2004	CN1182149C Method for preparing glucoside in resveratrol of medicine to nourish liver and lowering fat
12/29/2004	CN1182109C ((Aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy
12/29/2004	CN1181889C Process for preparing oral insulin nano material
12/29/2004	CN1181886C Application of TNF-derived peptides in the treatment of oedema
12/29/2004	CN1181884C Medicine for treating diabetic nephropathy and its preparing method
12/29/2004	CN1181877C Medicine for treating diabetic nephropathy and its preparing method
12/29/2004	CN1181876C Medicine for treating diabetes and its preparing method
12/29/2004	CN1181875C Medicine for treating fat liver of obesity and its preparing method
12/29/2004	CN1181836C Chinese medicine composition for treating diabetes and its preparing process
12/29/2004	CN1181833C Instant sugar reducing medicine
12/29/2004	CN1181831C Medicine with functions of reducing sugar and reducing blood-fat and its preparation method
12/29/2004	CN1181822C Use of 2-amino-3,4-dihydro-quinazolines for producing medicament for treating or preventing diseases caused by ischaemia conditions
12/29/2004	CN1181766C Health-care beverage for diabetic
12/29/2004	CN1181759C Blood sugar, blood pressure and blood fat reducing health food containing Qingqian willow extract
12/29/2004	CN1181742C Blood pressure and blood fat lowering herbal food
12/29/2004	CA2613021A1 Fluvastatin sodium crystal form lxxx, processes for preparing, compositions and methods of using
12/29/2004	CA2613013A1 Fluvastatin sodium crystal form lxxiii, processes for preparing, compositions and methods of using
12/29/2004	CA2610635A1 Fluvastatin sodium crystal form lxxxvii, processes for preparing, compositions and methods of using
12/29/2004	CA2610633A1 Fluvastatin sodium crystal form lxxix, processes for preparing, compositions and methods of using
12/29/2004	CA2534748A1 Relaxin superfamily peptide analogues
12/29/2004	CA2534094A1 Glycosidase inhibitors and methods of synthesizing same
12/29/2004	CA2529860A1 Ophthalmic composition
12/29/2004	CA2529859A1 Fluvastatin sodium crystal forms xiv, lxxiii ,lxxix, lxxx and lxxxvii, processes for preparing them, compositions containing them and methods of using them
12/29/2004	CA2529820A1 Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them
12/29/2004	CA2529462A1 An agent for improving physiological motor functions
12/29/2004	CA2529268A1 Pharmaceutical formulations of amyloid inhibiting compounds
12/29/2004	CA2529253A1 2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders
12/29/2004	CA2529154A1 Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions
12/29/2004	CA2528234A1 Propionic acid derivatives useful in the treatment of lipid disorders
12/29/2004	CA2527806A1 Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/29/2004	CA2523015A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists
12/28/2004	US6835846 Aliphatic compounds, process for their preparation and their usage
12/28/2004	US6835752 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
12/28/2004	US6835751 Bicyclic amino acids as pharmaceutical agents
12/28/2004	US6835749 Sulfohydroxamic acids and sulfohydroxamates and their use as MEK inhibitors
12/28/2004	US6835738 Phenylalanine enamide derivatives
12/28/2004	US6835737 Quinoline inhibitors of cGMP phosphodiesterase
12/28/2004	US6835731 Chemokine receptor binding heterocyclic compounds
12/28/2004	US6835730 4-heteroparyl-1,4-diazabicyclo[3.2.2]nonane, preparation and therapeutic use thereof
12/28/2004	US6835729 2-phenyl-1-[4(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
12/28/2004	US6835727 Bone disorders; osteoporosis; rheumatic diseases
12/28/2004	US6835711 Use of poly-Glu,Tyr for neuroprotective therapy
12/28/2004	US6835546 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
12/28/2004	US6835372 Mixtures of di-(tri)peptides and drugs such as cyclosporin used as aerosols; drug delivery
12/28/2004	CA2226039C Pyridylfuran and pyridylthiophene compounds
12/28/2004	CA2117199C Method for the treatment of the complications and pathology of diabetes
12/28/2004	CA2054358C High acid nutritional formulations
12/23/2004	WO2004111234A1 Novel protein

1 ... 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 ... 1298